Radioactive Materials. Buyer understands and acknowledges that property located within one thousand feet (1000') of the Property is currently being used for commercial engineering and manufacturing in the field of nuclear power, including the use, operation and/or production of high temperature gas-cooled reactors, radioisotope and radiopharmaceutical substances, fusion, and research and development activities related thereto. At one time, the Property was part of the real property covered by Special Nuclear Materials License No. SNM-696 issued by the U.S. Nuclear Regulatory Commission ("NRC") and License No. 0145-80 issued by the California Department of Health Services, Radiologic Health Branch ("CDHS"). In 1988, upon the request of General Atomics, the licensee, the NRC released approximately 277 acres, including the Property, from License No. SNM-696 for unrestricted use, after an investigation and evaluation of the site. The release is evidenced by notice from the NRC dated June 22, 1988. Effective September 15, 1988, CDHS amended License No. 0145-80 to release such 277 acres, including the Property. To Seller's knowledge, remedial cleanup action on the Property was required by the NRC or CDHS prior to release of the Property from such Licenses. Seller does not have the requisite information to determine the exact nature or condition of the Property or the effects such uses have had on the physical condition of the Property.
Appears in 2 contracts
Sources: Purchase and Sale Agreement (Neurocrine Biosciences Inc), Purchase and Sale Agreement (Neurocrine Biosciences Inc)